Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES WAYNE MCKINLEY

Allopathic & Osteopathic Physicians Family Medicine Sports Medicine

NPI
1902896863
CMS profile
222791
Location
TYLER, TX

General Payments · PY2018–2024

$266,828.04

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$69,199.96

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $69,199.96 24

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $69,199.96 24

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $26,544.94 12
PY2019 $28,815.56 13
PY2020 $29,900.00 12
PY2021 $30,122.15 13
PY2022 $37,178.79 15
PY2023 $45,066.64 16
PY2024 $69,199.96 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137633119 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137633121 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137633123 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137633125 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137633127 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137633129 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137633131 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137633133 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137633135 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137633137 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137633139 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137633141 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137633143 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,033.33 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137633145 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137633147 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,133.33 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137633149 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137633151 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,133.33 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137633153 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137633155 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,133.33 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137633157 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137633159 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,133.33 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137633161 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137633163 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,133.33 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137633165 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.